Search - tctmd.com

Displaying 561 - 580 of 596

Sort: Relevancy | Date

News Industry News

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

November 19, 2015

News Daily News

没有钱就得不到药物：全球范围内心血管疾病二级预防的障碍

Caitlin E. Cox

October 27, 2015

News Daily News

Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular

Caitlin E. Cox

October 27, 2015

News Daily News

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Caitlin E. Cox

October 27, 2015

Presentation

Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries

Presenter: R. Khatib

October 26, 2015

News Industry News

Laguna Pharmaceuticals Initiates Phase 3 Study of Vanoxerine in Atrial Fibrillation and Atrial Flutter

September 14, 2015

News Daily News

急性心梗发作后的心脏康复与生存率改善、用药依从性相关

Leah Lawrence

August 30, 2015

News Daily News

La Rehabilitación Cardíaca Post-IAM se asoció a una Mejor Supervivencia y Adherencia a la Medicación

Leah Lawrence

August 30, 2015

News Daily News

Cardiac Rehab After Acute MI Linked to Improved Survival, Medication Adherence

Leah Lawrence

August 30, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Industry News

UK launch for Daiichi's bloodthinner Lixiana

July 10, 2015

News Daily News

通常在急性心肌梗死后不给老年患者使用ICD，结果受到不利影响

Todd Neale

June 25, 2015

News Daily News

Los Pacientes Ancianos Víctimas de un IAM No Suelen Recibir un DCI y tienen Peores Resultados

Todd Neale

June 25, 2015

News Daily News

ICDs Often Not Given to Older Patients After Acute MI, Outcomes Suffer

Todd Neale

June 25, 2015

News Industry News

One-Year Outcomes Data on Stroke Prevention in Patients With Newly Diagnosed Atrial Fibrillation (AF) to Be Presented at ISTH 2015

June 18, 2015

News Industry News

Independent Study Finds Intravenous Vernakalant Facilitates Electrical Cardioversion in Patients with Cardioversion Resistant Atrial Fibrillation

June 12, 2015

News Industry News

Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies

May 28, 2015

News Industry News

Patients Undergoing Catheter Ablation Presented at Heart Rhythm 2015

May 15, 2015

News Industry News

Boston Scientific Announces First U.S. Commercial Procedures With The WATCHMAN™ Left Atrial Appendage Closure Device

March 24, 2015

News Daily News

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

Caitlin E. Cox

November 19, 2014

Advertisement

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

没有钱就得不到药物：全球范围内心血管疾病二级预防的障碍

Sin Dinero Ni Medicamentos: Barreras Globales a la Prevención Secundaria de la Enfermedad Cardiovascular

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries

Laguna Pharmaceuticals Initiates Phase 3 Study of Vanoxerine in Atrial Fibrillation and Atrial Flutter

急性心梗发作后的心脏康复与生存率改善、用药依从性相关

La Rehabilitación Cardíaca Post-IAM se asoció a una Mejor Supervivencia y Adherencia a la Medicación

Cardiac Rehab After Acute MI Linked to Improved Survival, Medication Adherence

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

UK launch for Daiichi's bloodthinner Lixiana

通常在急性心肌梗死后不给老年患者使用ICD，结果受到不利影响

Los Pacientes Ancianos Víctimas de un IAM No Suelen Recibir un DCI y tienen Peores Resultados

ICDs Often Not Given to Older Patients After Acute MI, Outcomes Suffer

One-Year Outcomes Data on Stroke Prevention in Patients With Newly Diagnosed Atrial Fibrillation (AF) to Be Presented at ISTH 2015

Independent Study Finds Intravenous Vernakalant Facilitates Electrical Cardioversion in Patients with Cardioversion Resistant Atrial Fibrillation

Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies

Patients Undergoing Catheter Ablation Presented at Heart Rhythm 2015

Boston Scientific Announces First U.S. Commercial Procedures With The WATCHMAN™ Left Atrial Appendage Closure Device

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content